CSI Market
Sign In | Register

Clearside Biomedical Inc (CLSD) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CLSD Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Clearside Biomedical Inc manages assets, liabilities, and equity through different cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2025)
(Jun 30 2025) (Mar 31 2025) (Dec 31 2024) (Sep 30 2024)
Assets
Cash & cash equivalent6.80
Short-term Investments, Total0.00
Cash & Short-term Investments6.00
Accounts receivable0.27
Other Current Assets0.00
Prepaid Expense, Current AS1.19
Total Current Assets8.25
Equipment/Property/Plant Net2.98
Other Assets, Noncurrent0.41
Operating Lease Right Of Use Asset0.38
Total Assets11.64
Liabilities
Accounts Payable, Current AC0.80
Accrued Liabilities, Current AC1.59
Other Liabilities, Current0.00
Total Current Liabilities2.77
Total Long-term Debt0.00
Other liabilities, Noncurrent62.82
Operating Lease Liability Current0.38
Operating Lease Liability Noncurrent0.06
Total Liabilities65.59
Stockholders' Equity
Common Stock Value0.08
Additional Paid In Capital Common Stock319.94
Retained Earnings / Accumulated Deficit-373.97
Other Equity0.00
Common Stockholder's Equity-53.95
Total Stockholder's Equity-53.95
Liabilities & Stockholder's Equity11.64
4 historic quarters locked

Sign in to unlock the full Clearside Biomedical Inc balance sheet history.

Sign In Create Free Account

About Clearside Biomedical Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20250930)
  • Filed with the SEC: November 14, 2025
  • Source: clsd-20250930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-25-282949

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.